Active Pharmaceutical Ingredients
- Industrial Coatings
- Dyes and Pigments
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
- Analytical Chemistry
- Pharmaceutical Intermediates
Popular Science Collection-1
According to the latest data from the National Cancer Center, lung cancer is the malignant tumor
with the highest incidence and mortality in China.
November is Global Lung Cancer Awareness Month, and November 17 is International Lung Cancer Day
【Abstract】In 2020, there were 9.
96 million deaths from lung cancer worldwide, including 1.
8 million lung cancer deaths, far exceeding other cancer types and ranking first
in cancer deaths.
In 2020, China will have 3 million cancer deaths and lung cancer deaths, up to 710,000, accounting for 23.
of the total cancer deaths.
In 2020, there were 19.
29 million new cases of cancer and 2.
2 million cases of lung cancer worldwide, ranking second; However, among the 4.
57 million new cancers in China, lung cancer ranked first with
Globally, in the past decade from 2010 to 2019, the incidence of TBL (trachea, bronchial and lung cancer) jumped from the original third place to the second place; Of the total cancer burden, TBL was the leading cause of cancer death (18.
In China, lung cancer is the leading cause of cancer deaths, accounting for about 27% of total cancer deaths; Lung cancer is the most common fatal cancer
in men aged 60 and older and women aged 45 and older.
Among the new cancers, lung cancer ranked first among men (24.
6%) and second
【Abstract】The data show that the incidence of lung cancer ranks first in men and second in women; Malignant mortality is lung cancer in both men and women; 40% of cancers can be prevented, and cultivating a science-based lifestyle such as quitting smoking can reduce the risk of
Based on 2020 global cancer burden data and United Nations demographic data estimates, the situation in 2022 is forecast: the number of new cancer cases in China is about twice that of the United States, and the number of deaths is about 5 times
that of the United States.
In 2022, lung cancer remains the most common cancer in China and the leading cause
of cancer death in China and the United States.
There are about 654,620 lung cancer survivors in the United States, and 236,740 new patients are expected in 2022, and more than half (55%) of lung cancer survivors have been diagnosed in the past 5 years; Lung cancer usually has no obvious symptoms in the early stage, and most patients are diagnosed at an advanced stage; The overall and 5-year relative survival rates for small cell lung cancer at all stages are lower than for non-small cell lung cancer
Since the early 90s of the 20th century, the overall 5-year relative survival rate has almost doubled
Lung cancer is the leading cause of cancer death in Americans, with more than 350 people dying
from lung cancer every day.
In recent years, lung cancer mortality has declined
dramatically due to fewer smokers and advances in early detection and treatment.
In France, lung cancer is the second most common cancer in men and the third most common cancer
Studies have shown that more women, more never-smokers, develop lung cancer; Lung adenocarcinoma is on the rise; Non-small cell lung cancer mortality has decreased